- Patent Title: Formulations of lixivaptan for the treatment of polycystic disease
-
Application No.: US16620144Application Date: 2018-06-08
-
Publication No.: US11241441B2Publication Date: 2022-02-08
- Inventor: Lorenzo Pellegrini
- Applicant: PALLADIO BIOSCIENCES, INC.
- Applicant Address: US PA Newtown
- Assignee: PALLADIO BIOSCIENCES, INC.
- Current Assignee: PALLADIO BIOSCIENCES, INC.
- Current Assignee Address: US PA Newtown
- Agency: Morgan, Lewis & Bockius LLP
- International Application: PCT/US2018/036719 WO 20180608
- International Announcement: WO2018/227128 WO 20181213
- Main IPC: A61K31/55
- IPC: A61K31/55 ; A61K31/5517 ; A61P13/12
Abstract:
Formulations of lixivaptan, and methods of using the same, are provided for the treatment of polycystic disease.
Public/Granted literature
- US20200147102A1 FORMULATIONS OF LIXIVAPTAN FOR THE TREATMENT OF POLYCYSTIC DISEASE Public/Granted day:2020-05-14
Information query
